MISSIONS THAT MATTER

Case studies



Uncommon

Good

From researching and escalating a leukemia cluster amongst US military children in the Southwest, to FDA and missile defense innovation, to cyber audit for a $4 trillion Bank of America portfolio; we deliver transformative outcomes acrpss arenas.


REGULATORY INNOVATION

First FDA Approval for AI-Driven Covid Treatment

Pioneering AI + Lit Review  -  No Animal Labs

DC Strategic Group achieved a landmark regulatory milestone: the first-ever FDA (EUA) approval for a Covid treatment & cure validated entirely through AI analysis and comprehensive literature and ELISA review -- without traditional animal or human clinical trials.


Key Impacts

  • First approval of its kind in FDA history
  • Set precedent for AI-validated drug testing, including Alphabet-Harvard AI test portal
  • Focus on antiviral treatment, not vaccines
  • Accelerated path to patient access
  • This early work with Pfizer supported Paxlovid development

This approval helped pave the way for 2026 US policy forbidding animal labs in Big Pharma, and all animal cruelty, formulated by President Donald Trump and HHS Secretary Robert Kennedy, Jr.

More Case Studies

DOJ l 500+ Russian targets identfied and flagged to the US, UK
  • Our work prompted at least 2 DOJ indictments against senior Russian officers, the first that Pravda & Putin ever reacted to
  • The UK Treasury used our intel for its Top 10 War Crimes warrants list
  • We flagged NPP & AO IZUMRUD, energy companies with Miami offices, linked to the the murder of Mariupul's mayor

MORE >>


NTSB l CEO Lucy Carpenter has said since Day 1 that the  Jan '25 Black Hawk-AA crash wasn't the pilots' fault

The Tower  broke Federal law by using Runway 33 with helicopter traffic >>

NPR l Senior Tax and Audit Strategy

Non-profits must be accurate in categorizing income, property, and assets >>

Buffett l UK advisory for Berkshire Hathaway's Marmon Grp

 After a routine business assignment for a London-based Buffet company, we were asked to stay on and advise Marmon on acquisition tech targets